Apimeds Pharmaceuticals
Pharmaceutical company focused on merger and financing activities.
About
Apimeds Pharmaceuticals US, Inc. is a pharmaceutical company involved in merger and financing transactions. The company announced a settlement with Inscobee Inc.
Similar companies
A leading global contract development and manufacturing organization (CDMO) for innovative biologic and small molecule therapies.
Shares Pharmaceuticals, Biotechnology
Develops, manufactures, and markets radiopharmaceuticals for diagnostic and therapeutic applications.
Shares Pharmaceuticals, Biotechnology
Azurity Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing high-quality, affordable liquid medications.
Shares Pharmaceuticals, Biotechnology
International specialty pharmaceutical company focused on central nervous system, pain management, and addiction treatments.
Shares Pharmaceuticals
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Pharma company
Shares Pharmaceuticals
Key facts
- Headquarters
- Matawan, New Jersey, US
- Total funding
- $100M (PIPE)
- Business model
- B2B
Frequently asked
What does Apimeds Pharmaceuticals do?
and Apimeds Inc. to resolve disputes arising from a merger with MindWave Innovations Inc. This settlement paves the way for the completion of the merger and a $100 million PIPE financing.
How much funding has Apimeds Pharmaceuticals raised?
Apimeds Pharmaceuticals has raised a total of $100M in funding. The most recent round on record is PIPE.
SEC filings, insider activity, nonprofit links and pay benchmarks for Apimeds Pharmaceuticals:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
